Diaphragmatic fatigue during sepsis-Mechanisms and therapy
Diaphragmatic fatigue during sepsis-Mechanisms and therapy
批准号:
09671579
负责人:
WATANABE Hiroaki
金额:
$1.6万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
本研究旨在探讨腹腔脓毒症大鼠离体血管收缩力的变化及其机制。腹腔内脓毒症是使用盲肠结扎穿孔技术(CLP)。通过离体血管收缩特性和力-频率曲线评价血管收缩力。在第一项研究中,我们调查了CLP后血管收缩力的时程变化。CLP后10小时开始出现膈肌收缩功能障碍,CLP后16小时进一步减少。在第二项研究中,我们研究了PEG-SOD、PEG-CAT和DMSO对脓毒性腹膜炎大鼠离体血管收缩力和MDA水平以及两种主要抗氧化酶超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)活性的影响。CLP前30 min和CLP后12 h分别腹腔注射PEG-SOD、PEG-CAT和DMSO。CLP后膈肌MDA水平显著升高。PEG=SOD、PEG-CAT和DMSO可明显改善CLP后大鼠血管的收缩功能,并可抑制CLP后血管MDA水平的升高。CLP后膈肌SOD活性明显升高。这些结果表明,几种类型的氧源性自由基在CLP后血管收缩性降低中起作用。
英文摘要
We investigated the alteration and mechanisms in diaphragmatic contractility in intra-abdominal sepsis in vitro. Intra-abdominal sepsis was produced using the cecal ligation and perforation technique (CLP). We assessed the diaphragmatic contractility by twitch characteristics and force-frequency curves in vitro. In the first study, we investigated the time course changes in diaphragmatic contractility after CLP. Diaphragmatic contractile dysfunction was began to develop 10hr after CLP and further reduction was observed 16hr after CLP. In the second study, we investigated the effects of PEG-SOD, PEG-CAT and DMSO on diaphragmatic contractility and MDA levels in septic peritonitis and the activities of two main antioxidant enzymes, superoxide dismutase (SOD) and glutathione peroxidase (GPx) in vitro. PEG-SOD, PEG-CAT and DMSO were administered intraperitoneally 30 min before and 12h after CLP. Diaphragmatic MDA levels were significantly elevated after CLP. PEG=SOD, PEG-CAT and DMSO significantly improved diaphragmatic contractility and prevented the elevation in diaphragmatic MDA levels after CLP. Diaphragmatic SOD activities were significantly increased after CLP. These results suggest that several types of oxygen-derived free radicals play a role in the reduction in diaphragmatic contractility after CLP.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
NARIMATSU,E., NAKAYAMA,Y., SUMITA,S., IWASAKI,H., FUJIMURA,N., SATOH,K., NAMIKI,A.: "Sepsis attenuates the intensity of the neuromuscular effect of d-Tubocurarine and the antagonistic actions of neostigmine and edrophonium."Acta Anaesth Scand. 43. 196-201
NARIMATSU,E.、NAKAYAMA,Y.、SUMITA,S.、IWASAKI,H.、FUJIMURA,N.、SATOH,K.、NAMIKI,A.:“脓毒症会减弱 d-筒箭毒碱的神经肌肉作用强度,并且
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
FUJIMURA,N., SUMITA,S., NARIMATSU,E., NAKAYAMA,Y., SHITINOHE,Y., NAMIKI,A.: "Effects of Isoproterenol on Diaphragmatic Contractility in Septic Peritonitis."Am J Respir Crit Care Med. 161(2). 440-446 (2000)
FUJIMURA,N.、SUMITA,S.、NARIMATSU,E.、NAKAYAMA,Y.、SHITINOHE,Y.、NAMIKI,A.:“异丙肾上腺素对脓毒症腹膜炎膈肌收缩力的影响。”Am J Respir Crit Care Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
住田臣造、並木昭義: "Molecular biologyからみたショックの病態-heat shock proteinを中心に" 集中治療. 10. 377-385 (1998)
Shinzo Sumita,Akiyoshi Namiki:“从分子生物学角度看休克的病理学 - 关注热休克蛋白”重症监护。 10. 377-385 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Narimatsu E,Nakayama Y,Aimono M: "Phosphodiesterase III,inhibitor,antagonizes the neuromuscular blocking effect of a non-depolarizing muscle reloxant"Res Commun Mol Pathol Pharmacol. 104. 219-228 (1999)
Narimatsu E,Nakayama Y,Aimono M:“磷酸二酯酶 III,抑制剂,拮抗非去极化肌肉松弛剂的神经肌肉阻断作用”Res Commun Mol Pathol Pharmacol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
住田臣造、七戸康夫ら: "敗血症と熱ショック蛋白質" 日本ショック学会雑誌. 13. 40-44 (1998)
Shinzo Sumita、Yasuo Shichinohe 等:“败血症和热休克蛋白”,日本休克学会杂志 13. 40-44 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
Design of a new high-intensity KL beamline
-
批准号:25800165
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.58万
-
财政年份:2013
-
负责人:WATANABE Hiroaki
-
依托单位:
海外基金